Your SlideShare is downloading. ×
0
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

VIV Animal Health Summit Closing CEO-level Conference, Mr. James Campbell, VIV Asia 2013

421

Published on

Presentation given by Mr. James Campbell during the VIV Animal Health Summit Conference, March 14, at VIV Asia 2013

Presentation given by Mr. James Campbell during the VIV Animal Health Summit Conference, March 14, at VIV Asia 2013

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
421
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Is there a problem withantimicrobial resistance in humans & animals?
  • 2. Problems with antimicrobial resistance data 1 3 2 Clinician/Vet Microbiologist Pharmacist
  • 3. % Antimicrobial resistance in Camp.jejuni in pigs & poultry in %resistance in Campylobacter coli in pigs & poultry from Dong Thap Dong Thap Provence Feb 2012 (N =98) Province 2012 (N = 78) 100100 80 80 60 60 40 40 20 0 20 AMP AMC CRO CAZ Cl NA CIP OFX CN SXT DA ERY ESBL+ 0 antibiotic AMP CRO CL CIP CN DA ESBL+ % antimicrobial resistance in % antimicrobial resistance in Campylobacter jejuni children <5 years in HCMC Campylobacter coli children <5 years in HCM 2009- 2009-2010 (N=69) 100 2010 (N=91) 100 90 80 80 70 60 60 50 40 40 30 20 20 10 0 0 AMP AMC CRO CAZ Cl NA CIP OFX CN SXT DA E ESBL E NA Cl CN P DA T P C Z X O CI SX CA AM OF AM s CR po pos BL ES
  • 4. % resistance in E.coli from diseased pigs Dong Thap & Tien Giang 2005 (N = 50)100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% OFX CIP CRO CAZ AMC C CN SXT AMP % resistance in E.coli from children with diarrheoa (N= 204) 2011-2012 HMC100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% OFX CIP CRO CAZ AMC C CN SXT AMP
  • 5. % resistance in E.coli March – December 2012 Amoxicilin AMC Ceftazidine CAZ Ceftriaxone CRO Cloramphenicol C Meropenem MEM Tetracyclin TE Trimethoprim- sulfamethoxazole SXT Amikacin AK Gentamycine CN Ciprofloxacin 5 CIP5 Ampicillin AMP Chicken and Human data: from VIBRE study in Tien Giang 5 Colonies / individual sample
  • 6. Comparison antimicrobial resistance non-typhoid Salmonella spp. from humans and animals in southern March – December 2012 human diarroheoa N = 79 70 human asymptomatic N = 92 60 animal N = 743 50 40% 30 20 10 0 AMP AUG CRO CAZ C CIP CN OFX SXT antibiotic
  • 7. % antimicrobial resistance in E.coli & Salm spp from market rats in Dong Thap Province Jan 2013 (E.coli N=532: Salm.spp N=37) E.coli 26 Salm.spp 24 22 20 18 16 14% 12 10 8 6 4 2 0 AMC CAZ CRO C MEM TE SXT AK CN CIP5 AMP ESBL % Antimicrobial resistance in S.suis in rats (S.suis N=6)70605040302010 0 CM RD LE IMP OX ERY P TE FEP SXT VA CRO
  • 8. Antimicrobial use in Viet NamUse at a farm levelUse in the communityDetails of use of antimicrobials in humans withinthe hospital settingUse in veterinary situations through The AnimalHealth Departments
  • 9. Normal pig feed!Chlotetracyline50 mg/kg
  • 10. Number (percentage) of chicken farms where antimicrobials were present in the medicine cabinet No. mediumAntimicrobial farms No. small farms Total No. of farmsgroups ( N=34 ) ( N=30 ) ( N=64 )Macrolides 13 ( 38% ) 4 (13% ) 17 ( 27% )Penicillins 10 (29% ) 8 (27% ) 18 (28% )Phenicols 6 ( 18% ) 1 ( 3% ) 7 ( 11% )Quinolones 12 ( 35% ) 9 (30% ) 21 ( 33% )Tetracyclines 13 ( 38% ) 13 (43% ) 13 (38% )Aminoglycosids 2 ( 6% ) 4 ( 13% ) 6 ( 9% )Sulfonamides 3 ( 9% ) none 3 ( 5% )Polypeptides 8 ( 24% ) 11 (37% ) 19 (30% )Lincosamides 2 ( 6% ) none 2 ( 3% )
  • 11. Number (percentage) of households where antimicrobials were present in the family medicine cabinet No. of farm No. of rural No. of urban Total No. ofAntimicrobial households households households householdsgroups (N=24 ) (N=24 ) (N=15 ) ( N=63 )Aminopenicillis 7 ( 29% ) 5 (21% ) 3 ( 20% ) 15 ( 24% )Cephlasporins 10 (42% ) 20 (83% ) 6 (40% ) 36 (57% )Lincosamides 1 ( 4% ) none 1 ( 7% ) 2 (3% )Macrolides 5 ( 21% ) 6 ( 25% ) 4 (27% ) 15 ( 24% )Quinolones 1 ( 4% ) 2 ( 8% ) 1 ( 7% ) 4 ( 6% )Sulfonamides none none 1 ( 7% ) 1 ( 2% )Tetracyclines none 1 ( 4% ) 1 ( 7% ) 2 ( 3% )
  • 12. InterventionsRational use of antimicrobial in hospitalsControl of antimicrobials in communityDiagnostics in veterinary medicine in Viet Nam asopposed to blanket antimicrobial useChanging farm practices with a view to reducingantimicrobial resistance
  • 13. AcknowledgementsThe Microbiology Dept., • OUCRU:HTD: Bs.Lan • Prof. J. J. Farrar • N. V. M. Hoang • T. T. T. NgaAnimal Health Depts. • C. T. ThuyTien Giang Province • P. V. Minh • V. O. P. LinhL. M. Khanh • N. T. Son ChauDong Nai Province • OUCRU Zoonosis Group:T. V. Quang • N. T. HoaDong Thap Province • J. J. Carrique-Mas • VIBRE:N. B. Hien • N. V. Truong LL W E CO Wellcome Trust ME THE TR UST
  • 14. Xin Cam On !

×